Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Premature Infant: early-phase trial registry

3 of 10 indexed Premature Infant trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 3 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Premature Infant: 10 US clinical trials tracked, 3 recruiting.

Premature Infant is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Joseph Bliss, running 1 of these trials.

Enrollment posture brief

Registry condition premature-infant

OPEN 3 | RECR 30% | LATE 0 | EARLY 1 | RANK #1724 | SPON 1

Nearest open-share peer: Adrenocortical Carcinoma (30% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Premature Infant (this)30%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near Premature Infant

Premature Infant lists 3 open slots (30% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Premature Infant on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Premature Infant is recruiting below its size-band peers.

    3 of 10 indexed trials (30%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Premature Infant trials is spread across many organizations.

    Joseph Bliss accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.

  3. Most Premature Infant trials plan to enrol fewer than 100 people.

    Median target enrolment is 90 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.

  4. Premature Infant research leans observational.

    4 interventional and 6 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Premature Infant records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Medium-Chain Triglyceride (MCT) Oil Drug
1 trials
Resonance Raman Spectroscopy (RRS) Device
1 trials
iRes Warmer without ResusView Other
1 trials
iRes Warmer with ResusView Device
1 trials
ultrasound Device
1 trials
Phototherapy lights Device
1 trials
PEAPOD Infant Body Composition measuring device Device
1 trials
Cognitive Behavioral Therapy Behavioral
1 trials

US sites by state

Facility locations filed on Premature Infant trials. A trial with sites in several states counts in each.

Texas 2 trials
Rhode Island 2 trials
Ohio 2 trials
California 2 trials
Wisconsin 1 trials
Utah 1 trials
Pennsylvania 1 trials
New York 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Premature Infant page

10 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Premature Infant trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Joseph Bliss sponsors the most Premature Infant trials on record, review their full trial history before evaluating a specific study. See Joseph Bliss's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Premature Infant condition card totals 10 registered trials; most-linked intervention Medium-Chain Triglyceride (MCT) Oil; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.